Can MRI-Guided radiation zero in on prostate tumors with fewer side effects?

NCT ID NCT07769372

First seen Aug 17, 2026 ยท Last updated Aug 17, 2026

Summary

This trial is testing a new way to deliver radiation therapy for prostate cancer. Instead of standard radiation, it uses MRI to precisely target the tumor, potentially sparing healthy tissue and reducing side effects. The study will include about 20 adults with early-stage prostate cancer and will focus on safety and how well the treatment works.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
MR-guided stereotactic body radiation therapy (SBRT)
What this could lead to
If successful, this approach could offer a more precise, less damaging radiation treatment for prostate cancer, potentially reducing side effects and improving quality of life.
What could go wrong
This is a small pilot study, so results may not be conclusive. There is a risk of side effects from radiation, and the treatment may not be more effective than standard approaches.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE I PROSTATE CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope at Irvine Lennar

    Irvine, California, 92618, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.